EXCLUSIVE RETAILERn95maskcompany
Subjected to rigorous testing, this mask blocks 95% of very small (0.3 micron) particles. FDA Approved. CDC approval #84A-7796.
Validation tests were conducted in compliance with GLP regulation. Approved according to 42 CFR Part 84.
Revolutionary Innonix design decreases the transmission of one (or more than one) human pathogen by antibacterial, anti-fungal, and antiviral activity.
Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.
Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.
Built of high quality, soft materials to ensure comfort during periods of long wear. Plus, water resistant for a final layer of protection.
Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.
Effectively traps fine particles that make their way through the first two layers.
Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.
Copper and zinc ions within this layer cause structural rearrangement in the proteins, nucleic acids and lipids; inactivating and destroying pathogens and viruses within minutes. No infectious viruses will remain on the mask's surface.
Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.
Traps contaminated droplets using a special hydrophilic plastic that increases the permeation of liquids. Virus laden droplets are rapidly absorbed into this layer instead of remaining on the surface of the mask. An acidic coating creates a low pH environment - ultimately destabilizing the virus proteins.
Respokare® Anti-Viral Mask is highly effective against 18 common Seasonal & Pandemic Influenza Viruses, as well as a wide range of other pathogens, bacteria and fungi.
Even when wearing a mask with advanced filtration technology, if the mask does not sufficiently fit tightly around the face, it will deem the mask protection grossly ineffective.
Rigorous testing and years of R&D have deemed the Respokare® NIOSH N95 Respirator Mask highly effective against 18 common seasonal and pandemic influenza viruses.
The NIOSH approved N95 Respirator Facemask is made per industry standards. The ‘N95’ designation means that when the product is subjected to careful testing, it blocks at least 95% of very small (0.3 micron) test particles.
- NIOSH Approved N95 respirator Approval number 84A-7796
- Nelson Labs tested and approved according to 42 CFR Part 84
- Added patented anti-viral technology which inactivates 99.99% flu viruses
OnlyRespoKare®Anti-Viral NIOSHN95 Respirator does more than filtering –it “inactivates” pathogens.
- 99.99% virus and bacteria inactivation within 5 minutes.
- Tight-fitting to face as proven by various quantitative and qualitative fit tests.
- NIOSH approved
Vertical seam and malleable aluminum nose bridge ensure a good seal
- Very soft and comfortable material on the inside
- High breathability and filtration achieved
Lab tests confirm: No Virus Detected.
As demonstrated in in-vitro laboratory testing on 5 minutes contact with the surface of the respirator, under test contact conditions. "Amount of Pathogens Killed" by the Respokare® NIOSH respirator calculated relative to the amount of microbes recovered from an inactive control mask resulted in a 95% confidence level.
All validation tests were conducted in compliance with Good Laboratory Practice (GLP) regulations and pursuant to International Standards by certified independent laboratories in the United States.
Respokare® Anti-Viral Mask is highly effective against 18 common Seasonal & Pandemic Influenza Viruses
In addition to influenza viruses, Respokare® inactivates a wide range of other pathogens, bacteria and fungi listed below:
